课题基金 / 基金详情

Kir 3 Channel Subunits in Drug Abuse with GABAB Agonists

Kir 3 Channel Subunits in Drug Abuse with GABAB Agonists
GABAB 激动剂药物滥用中的 Kir 3 通道亚基
批准号:
7231414
负责人:
Paul A Slesinger
金额:
$44.49万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-15 至 2011-03-31

项目摘要

项目成果

Paul A Slesinger的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们建议研究日益流行的设计药物γ -羟基丁酸(GHB)对腹侧被盖区(中边缘多巴胺系统)神经元的急性作用。GHB的作用通过GABAB型的G蛋白偶联受体(gpcr)介导,激活下游效应物,如G蛋白门控的内向整流钾(Kir3或GIRK)通道。我们假设GIRK通道的特定组合在介导GABAg受体激动剂对中边缘多巴胺系统的急性奖赏效应中起主要作用。我们将(1)阐明g蛋白信号(RGS)调节因子在GABAB受体偶联效率中的作用,(2)评估GIRK通道亚基(GIRK1, GIRK2和GIRK3)在设置GABAB受体在VTA多巴胺和GABA神经元中的偶联效率中的作用,以及(3)确定VTA中异质GIRK通道的单通道特性和组装规则。我们将采用双管齐下的方法——一种系统级方法,包括对野生型、GIRK缺陷和转基因小鼠的急性脑切片进行膜片钳记录和双光子成像;细胞方法,包括膜片钳记录和先进的成像技术,从异种细胞和培养的VTA神经元中表达的GIRK通道。总之,这些研究将揭示大脑中GIRK通道组装和与GABAs受体偶联的细胞和分子事件,并阐明GIRK通道在决定GHB和相关药物在大脑中的疗效中的作用。公共卫生相关性。药物滥用是一个美国和世界范围的问题,影响着数百万人。滥用药物会产生强烈的奖赏感,这可能导致重复用药、依赖和成瘾。成瘾的特征是对无法控制的渴望的反应。最初的奖励效应以及渴望与中脑边缘多巴胺系统的激活有关。GHB的滥用在过去几年中急剧增加。通过揭示GIRK通道在介导GHB作用中的作用,我们可能会发现直接激活这些通道或改变与gpcr偶联效率的新药靶点。这种方法可能使GIRK通道成为治疗成瘾的强大药物靶点。
英文摘要
DESCRIPTION (provided by applicant): We propose to study the acute effects of the increasingly popular designer drug gamma-hydroxy butyric acid (GHB) on neurons in the ventral tegmental area (mesolimbic dopamine system). The actions of GHB are mediated through G protein-coupled receptors (GPCRs) of the GABAB type, activating downstream effectors, such as G protein-gated inwardly rectifying potassium (Kir3 or GIRK) channels. We hypothesize that specific combinations of GIRK channels play a primary role in mediating acute rewarding effects of GABAg receptor agonists on mesolimbic dopamine system. We will (1) elucidate the role of regulator of G-protein signaling (RGS) proteins in modulating the coupling efficiency of GABAB receptors, (2) asses the role of GIRK channel subunits (GIRK1, GIRK2, and GIRK3) on setting the coupling efficiency of GABAB receptors in dopamine and GABA neurons of the VTA, and (3) determine single-channel properties and rules of assembly of heteromeric GIRK channels in the VTA. We will use a two-pronged approach - a systems level approach involving patch-clamp recordings and two-photon imaging in acute brain slices from wild-type, GIRK- deficient, and transgenic mice; and a cellular approach, involving patch-clamp recordings and advanced imaging techniques from GIRK channels expressed in heterologous cells and in cultured neurons of the VTA. Together, these studies will reveal the cellular and molecular events underlying GIRK channel assembly and coupling to GABAs receptors in the brain, as well as elucidate the role of GIRK channels in determining the efficacy of GHB and related drugs in the brain. Public health relevance. Drug abuse is a US and world-wide problem affecting millions of people. Drugs of abuse impart strong sensations of reward, which may lead to repetitive drug administration, dependence and addiction. Addiction is characterized by relapse in response to uncontrollable cravings. The initial rewarding effects as well as the cravings are associated with the activation of the mesolimbic dopamine system. The abuse of GHB has increased dramatically over the last few years. By unraveling the role of GIRK channels in mediating GHB actions, we may reveal targets for new drugs that either directly activate these channels or alter the coupling efficiency to GPCRs. Such an approach may establish GIRK channels as formidable drug targets for treating addiction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determination of the GIRK channel proteome
Structural analysis of alcohol-dependent activation of GIRKs
Structural Analysis of Alcohol-dependent Activation of GIRKs
Structural Analysis of Alcohol-dependent Activation of GIRKs
海外基金